EC Dental Science

ELOC mutated renal cell carcinoma configures as a variant of renal cell carcinoma which histologically simulates clear cell renal cell carcinoma and clear cell papillary renal cell tumour. ELOC mutated renal cell carcinoma is constituted of aggregates of clear cells permeated with voluminous, clear cytoplasm. Tumour parenchyma is traversed by thick bands of fibromuscular tissue wherein the fibromuscular septa may induce a multi-lobular neoplastic appearance.

1. Tjota MY., et al. “TSC/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases”. Human Pathology 134 (2023): 124-133.
2. Batavia AA., et al. “ELOC-inactivated renal cell carcinoma: molecular features supporting classification as a distinct entity”. Modern Pathology 8 (2023): 100194.
3. Hu X., et al. “Clinical characteristics of molecularly defined renal cell carcinomas”. Current Issues in Molecular Biology 6 (2023): 4763-4777.
4. Liu Y., et al. “Exploration of morphological features of clear cell renal cell carcinoma with PBRM1, SETD2, BAP1, or KDM5C mutations”. International Journal of Surgical Pathology 8 (2023): 1485-1494.
5. Schiavoni V., et al. “Recent advances in the management of clear cell renal cell carcinoma: novel biomarkers and targeted therapies”. Cancers (Basel)12 (2023): 3207.
6. Image 1 Courtesy: Libre pathology.
7. Image 2 Courtesy: Europe PMC.